EEG will be recorded during all task time. The main outcome will be the area under de curve (AUC) of the grand averaged mean differences between event-related potencials (ERPs) elicited by target and non-target words at 100-200, 300-500 and 800-900 ms after stimulus presentation for parietal electrophysiological signal (Pz). The ERPs represent the averaged voltage of several trials.
Ketamine's Effect Changes the Cortical Electrophysiological Activity Related to Semantic Affective Dimension of Pain
Brief Summary
Intervention / Treatment
-
Ketamine (DRUG)S-ketamine will be administered in precalculated infusion rates to obtain a plasmatic level of 60 ng/ml
-
Placebo (DRUG)Administered in an identical way than ketamine.
Condition or Disease
- Acute Pain
- Chronic Pain, Widespread
- Schizophrenia
Phase
Study Design
Study type: | INTERVENTIONAL |
---|---|
Status: | Completed |
Study results: | No Results Available |
Age: | 18 Years to 40 Years |
Enrollment: | 24 (ACTUAL) |
Funded by: | Other |
Allocation: | Randomized |
Primary Purpose: | Treatment |
MaskingTRIPLE:
|
Clinical Trial Dates
Start date: | Jan 02, 2017 | ACTUAL |
---|---|---|
Primary Completion: | Nov 30, 2017 | ACTUAL |
Completion Date: | Nov 30, 2017 | ACTUAL |
Study First Posted: | Apr 16, 2019 | ACTUAL |
Results First Posted: | Aug 31, 2020 | |
Last Updated: | Apr 15, 2019 |
Sponsors / Collaborators
Participant Groups
-
S-Ketamine will be diluted in normal saline and administrated in a target controlled infusion using an infusion pump to obtain a plasma target of 60 ng/ml according to Domino's model. Infusion will start during the interval between the 3rd and 4th blocks of the task.
-
A previously prepared identical solution containing only normal saline will be infused at the same infusion rates of group ketamine.
Eligibility Criteria
Sex: | Male |
---|---|
Minimum Age: | 18 |
Maximum Age: | 40 |
Age Groups: | Adult |
Healthy Volunteers: | Yes |
* male healthy subjects with higher education level
Exclusion Criteria:
* do not understand Portuguese language
* obese patients (BMI \> 27 kg/m2)
* use of NSAID, steroids, analgesics, anticonvulsant drugs, as well as alpha and beta-blockers
* score ≥ 13 on Beck II Questionnaire
* sleep deprivation in the night before evaluation
Primary Outcomes
Secondary Outcomes
-
After viewing each word, volunteers were asked to classify them according to the semantic valence in the following categories: "positive," "negative" or "neutral."
-
Response times to word classification in oddball task
Other Outcomes
-
Euphoria will be rated using an analogue visual scale ranging of 0 to 10.
-
Sedation will be rated using an analogue visual scale ranging of 0 (completely awake) to 100 (sleeping).
More Details
NCT Number: | NCT03915938 |
---|---|
Other IDs: | 15-0019 |
Study URL: | https://clinicaltrials.gov/study/NCT03915938 |